Cargando…
Hormone replacement therapy and risks of oesophageal and gastric adenocarcinomas
Oesophageal and gastric adenocarcinoma share an unexplained male predominance, which would be explained by the hypothesis that oestrogens are protective in this respect. We carried out a nested case–control study of hormone replacement therapy (HRT) among 299 women with oesophageal cancer, 313 with...
Autores principales: | Lindblad, M, García Rodríguez, L A, Chandanos, E, Lagergren, J |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361087/ https://www.ncbi.nlm.nih.gov/pubmed/16404367 http://dx.doi.org/10.1038/sj.bjc.6602906 |
Ejemplares similares
-
Tamoxifen exposure and risk of oesophageal and gastric adenocarcinoma: a population-based cohort study of breast cancer patients in Sweden
por: Chandanos, E, et al.
Publicado: (2006) -
Sex-specific exposure prevalence of established risk factors for oesophageal adenocarcinoma
por: Rutegård, M, et al.
Publicado: (2010) -
Ethnicity in relation to incidence of oesophageal and gastric cancer in England
por: Coupland, V H, et al.
Publicado: (2012) -
Sex hormones and oesophageal adenocarcinoma: influence of childbearing?
por: Lagergren, J, et al.
Publicado: (2005) -
Prognosis of oesophageal adenocarcinoma and squamous cell carcinoma following surgery and no surgery in a nationwide Swedish cohort study
por: Kauppila, Joonas H, et al.
Publicado: (2018)